AMZN
Amazon.com, Inc.
AMZN has the edge over CVCO overall, supported by stronger valuation and stronger modeled upside.
CVCO
Cavco Industries, Inc.
CVCO's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CVCO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
CVCO's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CVCO in the historical PE scenario, which offers more potential upside but is not a forecast.
CVCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $256 | -60% |
| Fair | 23x | $541 | -16% |
| Forward | 24x | $642 | — |
| Expensive | 26x | $619 | -3.6% |
| Current | 27x | $642 | — |
Historical ranges are pointers, not guarantees.
CVCO's PE is in its expensive range at 27x. If earnings grow as analysts expect, today's price would be 24x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CVCO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
CVCO has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CVCO on earnings, with more consistent year-over-year improvement.
CVCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $26.42 | +12% |
| Q3 2026 | $23.61 | -2.8% |
| Q2 2026 | $22.99 | -0.1% |
| Q1 2026 | $23.98 | +16% |
| Q4 2025 | $22.97 | +13% |
| Q3 2025 | $24.29 | +37% |
| Q2 2025 | $23.02 | +34% |
| Q1 2025 | $20.71 | +13% |
| Q4 2024 | $20.34 | +3.1% |
CVCO earned $23.61 per share over the past year, down 2.8% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CVCO on profitability, with a higher operating margin.
CVCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $656.4M | +18% |
| Q2 2026 | $610M | +9.5% |
| Q1 2026 | $550.1M | +8.2% |
| Q4 2025 | $581M | +11% |
| Q3 2025 | $556.5M | +9.7% |
| Q2 2025 | $556.9M | +17% |
| Q1 2025 | $508.4M | +21% |
| Q4 2024 | $522M | +17% |
CVCO has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -0.5 points |
| Q2 2026 | 8.7% | -2.2 points |
| Q1 2026 | 9.4% | +1.8 points |
| Q4 2025 | 9.4% | -2.9 points |
| Q3 2025 | 11% | +1.5 points |
| Q2 2025 | 11% | +2.8 points |
| Q1 2025 | 7.6% | -1.3 points |
| Q4 2024 | 12% | +3.4 points |
CVCO's operating margin was 11% last quarter, down 0.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CVCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $66.7M | -3% |
| Q2 2026 | $49M | +5.5% |
| Q1 2026 | $59.3M | +83% |
| Q4 2025 | $57.6M | +78% |
| Q3 2025 | $68.7M | +38% |
| Q2 2025 | $46.4M | +9.4% |
| Q1 2025 | $32.5M | +126% |
| Q4 2024 | $32.3M | -21% |
CVCO has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CVCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -49.6K shares |
| 1 year | -3.2% | -258K shares |
| 3 years | -11% | -997K shares |
| 5 years | -17% | -1.5M shares |
| Available history | -17% | -1.6M shares |
CVCO has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $30M |
| Q2 2026 | $30M |
| Q1 2026 | $30M |
| Q4 2025 | $43.8M |
| Q3 2025 | $36.1M |
| Q2 2025 | $50M |
| Q1 2025 | $34.2M |
| Q4 2024 | $42.2M |
CVCO spent $134M buying back its own shares over the past year, down 18% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CVCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -1.7x | Net Cash |
CVCO has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CVCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.2 | Neutral |
| Stochastic | 77.7 | Neutral |
CVCO's weekly RSI is 61 (neutral) and its Stochastic is 78 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over CVCO on valuation relative to its sector.
CVCO PE vs Consumer Cyclical Sector
| Metric | CVCO | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 18x | 51% above |
| PE % | 91 | 47 | 44 pts above |
CVCO is trading at 27x earnings, a 51% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
CVCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $578.8 | 11% above |
| 20 week MA | $572.7 | 12% above |
| 50 week MA | $563.0 | 14% above |
| 100 week MA | $530.2 | 21% above |
| 200 week MA | $434.4 | 48% above |
CVCO is in an uptrend: it's above all five of its weekly moving averages, and 48% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CVCO on returns for 2026, with the stronger performance.
CVCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $194.0 | $181.5 | -6.5% |
| 2021 | $181.5 | $302.7 | +67% |
| 2022 | $302.7 | $226.9 | -25% |
| 2023 | $226.9 | $346.6 | +53% |
| 2024 | $346.6 | $443.3 | +28% |
| 2025 | $443.3 | $600.4 | +35% |
| 2026 YTD | $600.4 | $642.0 | +6.9% |
CVCO has finished higher in four of the last six years, two of them by more than 50%. It's up 6.9% so far in 2026.